Stay updated on Dapagliflozin in PRESERVED-HF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in PRESERVED-HF Clinical Trial page.

Latest updates to the Dapagliflozin in PRESERVED-HF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History now shows a new revision tag v3.3.2 and the prior v3.3.1 is removed, reflecting an update to the page's version history display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedA new Revision: v3.3.1 entry was added to the Record History, and the previous Revision: v3.2.0 entry was removed.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding/operating status banner on the page has been removed, replacing it with the standard page layout. This change affects site-wide messaging rather than the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check43 days agoChange DetectedThe new screenshot shows only cosmetic UI changes to the Record History page, with version history and study status data unchanged and no content additions or deletions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference11%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin in PRESERVED-HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in PRESERVED-HF Clinical Trial page.